Description
5-Amino-1MQ 50mg – NNMT Inhibitor Research Compound Australia
5-Amino-1MQ 50mg is an experimental small-molecule research compound listed by Peps Aussie Australia as reference material for scientific investigation, laboratory analysis and controlled experimental research.
5-Amino-1MQ has attracted scientific interest because of its inhibitory activity against nicotinamide N-methyltransferase (NNMT), an enzyme involved in nicotinamide metabolism and cellular methyl-group regulation.
NNMT participates in biochemical pathways involving nicotinamide, S-adenosyl-L-methionine (SAM) and the formation of methylated nicotinamide metabolites.
Experimental research involving NNMT inhibition has examined adipose tissue biology, cellular energy regulation, metabolic signalling and biochemical pathways associated with methyl-group balance.
Preclinical studies involving 5-Amino-1MQ and related NNMT inhibitors have explored how changes in NNMT activity may influence metabolic processes under controlled experimental conditions.
However, the available evidence is predominantly laboratory and animal research.
These findings do not establish that 5-Amino-1MQ produces clinically meaningful weight loss, improves metabolic health or has an established safety profile in humans.
Unlike many other materials in the Peps Aussie catalogue, 5-Amino-1MQ is not a peptide. It is a synthetic small-molecule compound investigated in enzyme inhibition and metabolic research.
Peps Aussie lists 5-Amino-1MQ in a nominal 50mg size for laboratory research and analytical applications.
Important: 5-Amino-1MQ is intended strictly for laboratory research and analytical purposes. It is not supplied for human or animal consumption, injection, administration, weight management, therapeutic use or clinical treatment.
What Is 5-Amino-1MQ?
5-Amino-1MQ, commonly described in research literature as 5-amino-1-methylquinolinium, is an experimental small-molecule inhibitor of nicotinamide N-methyltransferase.
NNMT is an enzyme that catalyses the methylation of nicotinamide using S-adenosyl-L-methionine as a methyl-group donor.
This biochemical reaction produces 1-methylnicotinamide and S-adenosyl-L-homocysteine.
NNMT therefore participates in pathways connecting nicotinamide metabolism with cellular methylation chemistry.
5-Amino-1MQ has been investigated as a chemical tool for studying NNMT-associated biological processes.
Relevant research areas include:
- NNMT enzyme inhibition.
- Nicotinamide metabolism.
- Cellular methyl-group balance.
- Adipose tissue biology.
- Metabolic signalling.
- Cellular energy regulation.
- Experimental small-molecule pharmacology.
- Enzyme structure–activity relationships.
These investigations contribute to understanding the biological role of NNMT.
Understanding Nicotinamide N-Methyltransferase (NNMT)
NNMT is an enzyme involved in the methylation of nicotinamide and certain related compounds.
Nicotinamide is a form of vitamin B3 and participates in pathways associated with nicotinamide adenine dinucleotide (NAD+) metabolism.
The NNMT reaction uses SAM as a methyl-group donor.
Research involving NNMT has examined:
- Nicotinamide methylation.
- Cellular methyl-group utilisation.
- SAM-associated metabolism.
- Nicotinamide metabolite production.
- Adipose tissue biology.
- Metabolic regulation.
- Tissue-specific enzyme expression.
NNMT activity varies across biological systems and may have different physiological implications depending on the tissue and experimental conditions.
5-Amino-1MQ Research and Scientific Applications
Published research involving 5-Amino-1MQ and related NNMT inhibitors spans several areas of enzyme pharmacology, metabolic biology and experimental biochemistry.
The following sections describe scientific research topics rather than proven therapeutic effects of the Peps Aussie material.
1. NNMT Enzyme Inhibition Research
One of the primary areas of 5-Amino-1MQ research involves inhibition of nicotinamide N-methyltransferase.
NNMT participates in biochemical reactions involving nicotinamide and cellular methylation pathways.
Researchers have investigated NNMT inhibitors to better understand the enzyme’s biological functions.
Relevant research topics include:
- NNMT catalytic activity.
- Enzyme inhibition.
- Substrate interactions.
- Small-molecule inhibitor design.
- Enzyme kinetics.
- Biochemical assay development.
- Structure–activity relationships.
These investigations contribute to understanding NNMT as an experimental molecular target.
2. Nicotinamide Metabolism Research
Nicotinamide is involved in several important biochemical pathways.
It is a precursor in NAD+ salvage metabolism and can also undergo methylation through NNMT.
Research involving NNMT inhibition has examined the relationship between these competing metabolic pathways.
Relevant topics include:
- Nicotinamide availability.
- Nicotinamide methylation.
- NAD+ salvage pathways.
- Metabolite production.
- Cellular biochemical regulation.
- Experimental metabolic flux.
These investigations contribute to understanding how nicotinamide is processed within biological systems.
However, NNMT inhibition does not automatically establish increased NAD+ concentrations or improved cellular energy metabolism.
3. Adipose Tissue Biology Research
NNMT has been investigated in adipose tissue and other metabolically active tissues.
Preclinical research has explored whether changes in NNMT activity influence metabolic characteristics under experimental conditions.
Relevant scientific topics include:
- Adipocyte biology.
- Adipose tissue metabolism.
- Lipid-associated pathways.
- Metabolic enzyme expression.
- Cellular energy regulation.
- Experimental tissue responses.
Studies involving 5-Amino-1MQ have contributed to interest in NNMT as a metabolic research target.
However, observations from laboratory and animal models do not establish that 5-Amino-1MQ reduces body fat or produces clinically meaningful weight loss in humans.
4. Cellular Energy Metabolism Research
Cellular energy metabolism involves interconnected pathways that support biochemical activity.
NNMT participates in metabolic processes involving nicotinamide and methyl-group utilisation.
Experimental investigations have examined the relationship between NNMT activity and cellular metabolic regulation.
Relevant research topics include:
- Cellular metabolic pathways.
- Energy-associated biochemical processes.
- Nicotinamide utilisation.
- Metabolic enzyme activity.
- Cellular signalling.
- Experimental metabolic responses.
These investigations contribute to understanding the complex relationship between enzyme activity and cellular metabolism.
They do not establish that 5-Amino-1MQ increases human energy levels or improves physical performance.
5. Methyl-Group Balance and SAM Metabolism
NNMT uses S-adenosyl-L-methionine (SAM) as a methyl-group donor.
SAM participates in numerous methylation reactions throughout biological systems.
Research involving NNMT has examined how enzyme activity may influence methyl-group utilisation.
Relevant research topics include:
- SAM-associated metabolism.
- S-adenosyl-L-homocysteine production.
- Methyl-group utilisation.
- Cellular methylation pathways.
- Metabolic regulation.
- Enzyme-associated biochemical changes.
These pathways are important for understanding the broader biochemical context of NNMT inhibition.
However, changes in methyl-group metabolism should not automatically be interpreted as beneficial.
6. NAD+ Pathway Research
NAD+ is an essential coenzyme involved in cellular oxidation–reduction reactions and other biochemical processes.
Nicotinamide is a component of NAD+ salvage metabolism.
Because NNMT also uses nicotinamide as a substrate, researchers have examined potential relationships between NNMT activity and NAD+-associated pathways.
Relevant scientific topics include:
- Nicotinamide availability.
- NAD+ salvage metabolism.
- Nicotinamide methylation.
- Metabolic pathway interactions.
- Cellular coenzyme regulation.
- Experimental biochemical measurements.
These investigations provide a scientific connection between NNMT research and NAD+ metabolism.
However, 5-Amino-1MQ is not NAD+, and its inhibitory activity does not establish that it functions as an NAD+ supplement or reliably increases NAD+ levels.
7. 5-Amino-1MQ Compared With NAD+ and Peptide Compounds
5-Amino-1MQ is sometimes discussed alongside peptides and other metabolic research materials.
However, these substances are chemically and functionally distinct.
5-Amino-1MQ:
- A synthetic small-molecule compound.
- Investigated as an NNMT inhibitor.
- Associated with nicotinamide metabolism research.
- Not a peptide or NAD+ precursor.
NAD+:
- A nucleotide-derived coenzyme.
- Participates directly in cellular redox reactions.
- Involved in energy metabolism and numerous biochemical processes.
- Not an NNMT inhibitor by definition.
Research peptides:
- Composed of amino acid residues connected by peptide bonds.
- May interact with receptors, enzymes or other biological targets.
- Have compound-specific structures and mechanisms.
These distinctions are important when interpreting experimental results.
8. 5-Amino-1MQ Analytical Characterisation and Quality Research
5-Amino-1MQ is also relevant to analytical investigations involving small-molecule identity, composition and material quality.
Laboratories evaluating 5-Amino-1MQ may investigate:
- Confirmation of chemical identity.
- Molecular structure verification.
- Molecular mass determination.
- Counterion or salt-form identification.
- Chromatographic purity profiles.
- Related chemical impurities.
- Quantitative content determination.
- Residual solvent analysis where relevant.
- Stability and degradation characteristics.
- Batch-to-batch analytical consistency.
Analytical techniques may include high-performance liquid chromatography (HPLC), mass spectrometry (MS), nuclear magnetic resonance (NMR) spectroscopy and other suitable methods.
The analytical method should be appropriate for the specific chemical form and formulation.
5-Amino-1MQ 50mg Research Compound Specifications
Peps Aussie lists 5-Amino-1MQ in a nominal 50mg size.
| Specification | Details |
|---|---|
| Product name | 5-Amino-1MQ |
| Listed size | 50mg |
| Compound type | Synthetic small-molecule compound |
| Chemical class | Amino-substituted methylquinolinium derivative |
| Research target | Nicotinamide N-methyltransferase (NNMT) |
| Research category | Enzyme inhibition and metabolic research |
| Research areas | NNMT inhibition, nicotinamide metabolism and adipose tissue biology |
| Peptide classification | Not a peptide |
| Exact salt form | Requires verification |
| Supplier | Peps Aussie Australia |
| Intended use | Laboratory research and analytical investigation only |
The scientific characteristics above describe 5-Amino-1MQ as discussed in research literature. They do not independently verify the identity, composition, purity or content of the supplied material.
Exact chemical identity, counterion or salt form, molecular mass, formulation, physical appearance, fill quantity and excipients should be confirmed against the applicable product label and supporting lot documentation.
Important: The labelled 50mg quantity should be interpreted according to the documented chemical form. Different salt forms may have different molecular masses and assay conventions.
5-Amino-1MQ Certificate of Analysis (COA) and Quality Documentation
Analytical verification is an important consideration when evaluating experimental small-molecule research compounds.
Peps Aussie maintains a dedicated resource where researchers can review available Certificates of Analysis and supporting analytical records.
View Peps Aussie Certificates of Analysis
When evaluating 5-Amino-1MQ analytical documentation, researchers should consider:
- Chemical identity: Whether testing supports the declared 5-Amino-1MQ identity.
- Structural verification: Whether the molecular structure has been appropriately characterised.
- Salt-form identification: Whether the counterion or chemical form has been established.
- Purity assessment: Whether suitable methods were used to evaluate impurities.
- Content determination: Whether quantitative testing supports the declared 50mg quantity.
- Batch traceability: Whether the certificate corresponds to the supplied production lot.
- Testing methodology: Whether the analytical techniques are appropriate for the compound.
- Additional testing: Whether relevant contamination, residual solvents or other quality assessments were performed.
High-performance liquid chromatography, mass spectrometry and NMR spectroscopy may support chemical characterisation.
However, a chromatographic purity result alone does not necessarily establish the complete chemical identity, salt form or quantitative content of the material.
A certificate should be interpreted according to the tests actually performed.
The availability of a certificate does not automatically establish sterility, a particular purity percentage, pharmaceutical-grade manufacturing or independent verification of every production batch.
5-Amino-1MQ Storage and Laboratory Handling
Experimental small-molecule compounds require appropriate handling to support sample integrity and experimental reproducibility.
Storage requirements for 5-Amino-1MQ depend on its exact chemical form, formulation, packaging and validated manufacturer stability information.
Laboratories should consider:
- Appropriate storage temperature.
- Protection from light and moisture where necessary.
- Suitable laboratory containers.
- Compatibility with analytical solvents.
- Chemical stability following sample preparation.
- Potential degradation during storage.
- Appropriate laboratory handling and disposal procedures.
No universal storage temperature or preparation procedure is recommended without verified product-specific documentation.
Storage guidance developed for peptide materials should not automatically be applied to 5-Amino-1MQ because it is a chemically distinct small molecule.
All laboratory work should be performed by appropriately qualified personnel using validated procedures and suitable safety controls.
5-Amino-1MQ 50mg Australia – Product Availability and Shipping
Peps Aussie maintains an Australian-based catalogue of research peptides, small-molecule compounds and laboratory materials for scientific and analytical applications.
5-Amino-1MQ 50mg is the currently listed nominal product size.
Pricing and ordering availability should be confirmed through the product selection area. Inventory is currently pending confirmation.
For current information regarding Australian dispatch, delivery arrangements, processing times and applicable restrictions, visit the Peps Aussie Shipping Policy.
Frequently Asked Questions About 5-Amino-1MQ
What is 5-Amino-1MQ?
5-Amino-1MQ is a synthetic small-molecule compound investigated as an inhibitor of nicotinamide N-methyltransferase (NNMT).
Is 5-Amino-1MQ a peptide?
No. 5-Amino-1MQ is a small-molecule chemical compound, not a peptide.
What is 5-Amino-1MQ studied for?
Preclinical research has examined 5-Amino-1MQ in relation to NNMT inhibition, adipose tissue biology, nicotinamide metabolism and cellular energy regulation.
What is NNMT?
NNMT stands for nicotinamide N-methyltransferase, an enzyme involved in the methylation of nicotinamide using SAM as a methyl-group donor.
Does 5-Amino-1MQ burn fat?
Preclinical research has examined metabolic endpoints associated with NNMT inhibition. These findings do not establish that 5-Amino-1MQ produces fat loss or clinically meaningful weight reduction in humans.
Is 5-Amino-1MQ approved for weight loss?
No approval is claimed for 5-Amino-1MQ as a weight-management medicine. It should not be represented as a validated weight-loss intervention.
Does 5-Amino-1MQ increase NAD+?
NNMT inhibition has been investigated in relation to nicotinamide metabolism and NAD+-associated pathways. However, this does not establish that 5-Amino-1MQ reliably increases NAD+ levels in humans.
Is 5-Amino-1MQ the same as NAD+?
No. 5-Amino-1MQ is an experimental NNMT inhibitor, while NAD+ is a coenzyme involved in cellular metabolism.
Has 5-Amino-1MQ been studied in humans?
The evidence base is predominantly preclinical. An established clinical safety and efficacy profile for human therapeutic use has not been demonstrated.
What size does Peps Aussie list?
Peps Aussie lists 5-Amino-1MQ in a 50mg nominal size. Researchers should verify the individual vial label and supporting analytical documentation.
Does 5-Amino-1MQ have a Certificate of Analysis?
Available analytical documentation can be reviewed through the Peps Aussie Certificates of Analysis page. Researchers should confirm that any applicable certificate corresponds to the specific production lot and evaluate the tests performed.
How should 5-Amino-1MQ be stored?
Storage requirements depend on the chemical form, formulation and validated stability characteristics. Follow the manufacturer’s product-specific documentation and established laboratory procedures.
Is 5-Amino-1MQ approved for human or veterinary use?
No medical or veterinary approval is claimed for the Peps Aussie 5-Amino-1MQ research product.
This product is not supplied for human or animal consumption, administration, diagnosis, prevention or treatment.
5-Amino-1MQ Research Compounds at Peps Aussie Australia
Peps Aussie maintains a catalogue of laboratory research peptides, small molecules and scientific materials for researchers investigating molecular biology, metabolic signalling and experimental pharmacology.
5-Amino-1MQ remains a subject of scientific interest because of its inhibitory activity against NNMT and its relevance to nicotinamide metabolism and metabolic enzyme research.
Researchers evaluating 5-Amino-1MQ 50mg should prioritise accurate chemical identification, confirmation of salt form, appropriate analytical documentation, batch traceability and validated laboratory procedures.
Explore the Peps Aussie research catalogue at pepsaussie.com.
Research Use Only Disclaimer
5-Amino-1MQ 50mg is intended strictly for laboratory research and analytical purposes only.
This product is not intended for human or animal consumption, injection, administration, weight management, therapeutic use or clinical treatment.
Descriptions of published scientific research are provided for educational and informational purposes only. They do not establish fat-loss benefits, metabolic enhancement, increased NAD+ levels, clinical safety or therapeutic suitability for the material offered.
Findings from preclinical studies should not be assumed to apply to humans or to the supplied 5-Amino-1MQ material without direct supporting evidence.
No dosing, self-administration or therapeutic guidance is provided.

Reviews
There are no reviews yet.